Skip to main content
AmigoFish

Rectal Cancer Treatment Algorithm - Multidisciplinary Approach with Drs. Madhu Eluri & Nina Sanford

From Oncology Brothers: Practice-Changing Cancer Discussions · · 19 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

In this segment of the treatment algorithms, we focused on rectal cancer treatment landscape with Dr. Nina Sanford, a radiation oncologist, and Dr. Madhu Eluri, MD, a medical oncologist.

In this episode, we discussed:

- The recent approval of dostarlimab for MSI-high rectal cancer and its implications for treatment

- The importance of a multidisciplinary approach in managing stage II and III rectal cancer

- The debate between total neoadjuvant treatment (TNT) versus the PROSPECT trial approach

- The role of chemotherapy, radiation, and surgery in various risk categories of rectal cancer

- How to monitor patients post-treatment and the significance of circulating tumor DNA (ctDNA) in decision-making

- Insights into the management of metastatic rectal cancer and the potential for organ preservation

Tune in for a comprehensive discussion that emphasizes the importance of biomarker-driven care and the evolving landscape of rectal cancer treatment.

Listen us on:

Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o

Follow us on social media:

•⁠ ⁠X/Twitter: https://x.com/oncbrothers

•⁠ ⁠Instagram: https://www.instagram.com/oncbrothers

•⁠ Website: https://oncbrothers.com/

Don't forget to like, subscribe, and hit the notification bell for more episodes from the Oncology Brothers!

#RectalCancer, #MultiD, #MSI-H, #TNT, #OncologyBrothers

Back to Oncology Brothers: Practice-Changing Cancer Discussions · Report a problem